Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Number of holders
-
1,405
-
Total 13F shares, excl. options
-
214,741,635
-
Shares change
-
+904,305
-
Total reported value, excl. options
-
$105,507,397,690
-
Value change
-
+$476,326,109
-
Put/Call ratio
-
110%
-
Number of buys
-
647
-
Number of sells
-
-567
-
Price
-
$491.22
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2022
1,553 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2022.
Elevance Health, Inc. - Common Stock (ELV) has 1,405 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 214,741,635 shares
of 225,970,109 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21,505,858 shares), VANGUARD GROUP INC (20,772,895 shares), STATE STREET CORP (10,628,193 shares), WELLINGTON MANAGEMENT GROUP LLP (10,129,421 shares), PRICE T ROWE ASSOCIATES INC /MD/ (8,755,851 shares), FMR LLC (6,879,028 shares), Capital International Investors (6,271,824 shares), BANK OF AMERICA CORP /DE/ (4,527,279 shares), BAILLIE GIFFORD & CO (4,172,392 shares), and Sanders Capital, LLC (4,081,861 shares).
This table shows the top 1,405 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.